Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2017-01-04 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE PETIT-QUEVILLY (76140), Seine-Maritime
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES CHARTREUX : revenue, balance sheet and financial ratios
PHARMACIE DES CHARTREUX is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE PETIT-QUEVILLY (76140),
this company of category PME
shows in 2024 a net income positive of 62 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES CHARTREUX (SIREN 824727085)
Indicator
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
62 196 €
71 242 €
105 205 €
115 510 €
83 552 €
91 175 €
82 228 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DES CHARTREUX generates positive net income of 62 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 82 k€ -> 62 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
62 196 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 76%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
75.679%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.982%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES CHARTREUX
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
Debt ratio
322.529
245.757
191.172
143.291
113.336
93.709
75.679
Financial autonomy
21.436
26.213
30.344
35.493
41.527
44.913
48.982
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
75.682024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of PHARMACIE DES CHARTREUX (75.68) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.98%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+6 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DES CHARTREUX (49.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 128.91. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
128.914
Liquidity indicators evolution PHARMACIE DES CHARTREUX
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
136.492
131.86
120.586
120.563
141.395
141.473
128.914
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
128.912024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Watch
In 2024, the liquidity ratio of PHARMACIE DES CHARTREUX (128.91) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE DES CHARTREUX in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DES CHARTREUX is estimated at
868 302 €
(range 604 671€ - 1 299 029€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
604k€868k€1299k€
868 302 €Range: 604 671€ - 1 299 029€
NAF 5 année 2024
Valuation method used
Net Income Multiple
62 196 €
×
14.0x
=868 302 €
Range: 604 672€ - 1 299 030€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES CHARTREUX with other companies in the same sector:
Frequently asked questions about PHARMACIE DES CHARTREUX
What is the revenue of PHARMACIE DES CHARTREUX ?
The revenue of PHARMACIE DES CHARTREUX is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DES CHARTREUX profitable?
Yes, PHARMACIE DES CHARTREUX generated a net profit of 62 k€ in 2024.
Where is the headquarters of PHARMACIE DES CHARTREUX ?
The headquarters of PHARMACIE DES CHARTREUX is located in LE PETIT-QUEVILLY (76140), in the department Seine-Maritime.
Where to find the tax return of PHARMACIE DES CHARTREUX ?
The tax return of PHARMACIE DES CHARTREUX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES CHARTREUX operate?
PHARMACIE DES CHARTREUX operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart